Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD

Respiratory Research

Volumn 18, Issue 1, 2017, Pages

  Westerik, Janine A M ^a   Metting, Esther I ^b   van Boven, Job F M ^b   Tiersma, Waling ^a   Kocks, Janwillem W H ^b   Schermer, Tjard R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; BLINDNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; DYSPEPSIA; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OSTEOPOROSIS; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROSTATE DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; COHORT ANALYSIS; MIDDLE AGED; MULTIPLE CHRONIC CONDITIONS; NETHERLANDS; PREVALENCE; PRIMARY HEALTH CARE; RECURRENT DISEASE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE CHRONIC CONDITIONS; NETHERLANDS; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85011661884     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-017-0512-2     Document Type: Article

References (45)

1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet (London, England). 2012;380(9836):37-43.
2. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2016. Available from: http://www.goldcopd.org/. Accessed 16 Jan 2017.
3. van Manen JG, IJzermans CJ, Bindels PJ, van der Zee JS, Bottema BJ, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol. 2001;54(3):287-93.
4. Negewo NA, McDonald VM, Gibson PG. Comorbidity in chronic obstructive pulmonary disease. Respir Invest. 2015;53(6):249-58.
5. Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015;36(4):575-91.
6. Wijnhoven HA, Kriegsman DM, Hesselink AE, de Haan M, Schellevis FG. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003;97(5):468-75.
7. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631-9.
8. Garcia-Olmos L, Alberquilla A, Ayala V, Garcia-Sagredo P, Morales L, Carmona M, et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract. 2013;14:11.
9. Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, Hanania NA, et al. A simplified score to quantify comorbidity in COPD. PLoS One. 2014;9(12):e114438.
10. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155-61.
11. de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Divo M, Zulueta JJ, et al. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax. 2014;69(9):799-804.
12. Okkes IM, Becker HW, Bernstein RM, Lamberts H. The March 2002 update of the electronic version of ICPC-2. A step forward to the use of ICD-10 as a nomenclature and a terminology for ICPC-2. Fam Pract. 2002;19(5):543-6.
13. WHO Collaborating Centre for Drug Statistics Methodology. 2015. Available from: http://www.whocc.no/. Accessed 16 Jan 2017.
14. Luijks H, Schermer T, Bor H, van Weel C, Lagro-Janssen T, Biermans M, et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 2012;10:128.
15. Snoeck-Stroband JB, Schermer TRJ, Van Schayck CP, Muris JW, Van der Molen T, In 't Veen JCCM, Chavannes NH, Broekhuizen BDL, Barnhoorn MJM, Smeele I, Geijer RMM, Tuut MK. NHG guideline COPD (third revision). Huisarts Wet. 2015;58(4):198-211.
16. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608-13.
17. Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, Boyd CM, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67(8):904-11.
18. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887-94.
19. Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest. 2012;142(5):1126-33.
20. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913-20.
21. Kruis AL, Stallberg B, Jones RC, Tsiligianni IG, Lisspers K, van der Molen T, et al. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One. 2014;9(3):e90145.
22. Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Vestbo J. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax. 2015;70(1):33-40.
23. Chan MC, Lin CH, Kou YR. Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality a nationwide health insurance data based retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:1053-9.
24. de Vries M, Berendsen AJ, Bosveld HE, Kerstjens HA, van der Molen T. COPD exacerbations in general practice: variability in oral prednisolone courses. BMC Fam Pract. 2012;13:3.
25. Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis. 2015;10:1935-49.
26. Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889-904.
27. James GD, Donaldson GC, Wedzicha JA, Nazareth I. Trends in management and outcomes of COPD patients in primary care, 2000-2009: a retrospective cohort study. NPJ Prim Care Respir Med. 2014;24:14015.
28. Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1):129-35.
29. Lange P, Tottenborg SS, Sorknaes AD, Andersen JS, Sogaard M, Nielsen H, et al. Danish Register of chronic obstructive pulmonary disease. Clin Epidemiol. 2016;8:673-8.
30. Triest FJ, Franssen FM, Spruit MA, Groenen MT, Wouters EF, Vanfleteren LE. Poor agreement between chart-based and objectively identified comorbidities of COPD. Eur Respir J. 2015;46(5):1492-5.
31. Vanfleteren LE, Franssen FM, Uszko-Lencer NH, Spruit MA, Celis M, Gorgels AP, et al. Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease. Am J Cardiol. 2011;108(11):1669-74.
32. Dijk WD, Bemt L, Haak-Rongen S, Bischoff E, Weel C, Veen JC, et al. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res. 2011;12:151.
33. Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med. 2009;180(12):1189-95.
34. Rolink M, van Dijk W, van den Haak-Rongen S, Pieters W, Schermer T, van den Bemt L. Using the DOSE index to predict changes in health status of patients with COPD: a prospective cohort study. Prim Care Respir J. 2013;22(2):169-74.
35. Numans ME, De Wit NJ, Dirven JAM, Heemstra-Borst CG, Hurenkamp GJB, Scheele ME, Burgers JS, Geijer RMM, De Jongh E. NHG guidelineStomach complaints (third revision). Huisarts Wet. 2013;56:26-3.
36. Smeele I, Barnhoorn MJM, Broekhuizen BDL, Chavannes NH, In 't Veen JCCM, Van der Molen T, Muris JW, Van Schayck O, Schermer TRJ, Snoeck-Stroband JB, Geijer RMM, Tuut MK. NHG-Werkgroep Astma bij volwassenen en COPD. [NHG guideline Asthma in adults (third revision)]. Huisarts Wet. 2015;58(3):142-54.
37. Van Weel-Baumgarten EM, Van Gelderen MG, Grundmeijer HGLM, Licht-Strunk E, Van Marwijk HWJ, Van Rijswijk HCAM, Tjaden BR, Verduijn M, Wiersma T, Burgers JS, Van Avendonk MJP, Van der Weele GM. [NHG guideline Depression (second revision). Huisarts Wet. 2012;55(6):252-9.
38. Spijker J, Bockting CLH, Meeuwissen JAC, Vliet IM V, Emmelkamp PMG, Hermens MLM, Balkom ALJM V, namens de Werkgroep Multidisciplinaire richtlijnontwikkeling Angststoornissen/Depressie. Multidisciplinaire richtlijn Depressie (Derde revisie). Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve stoornis. Utrecht: Trimbos-instituut; 2013.
39. Hassink-Franke LJA, Terluin B, Van Heest FB, Hekman J, Van Marwijk HWJ, Van Avendonk MJP. [NHG guideline Anxiety (second revision)]. Huisarts Wet. 2012;55(2):68-77.
40. Van Hof N, Balak FSR, Apeldoorn L, De Nooijer HJ, Vleesch Dubois V. Van Rijn-van Kortenhof. [NHG guideline Ulcus cruris venosum (second revision)]. Huisarts Wet. 2010;53(6):321-33.
41. Van Pinxteren B, Knottnerus BJ, Geerlings SE, Visser HS, Klinkhamer S, Van der Weele GM, Verduijn MM, Opstelten W, Burgers JS, Van Asselt KM. [NHG-guidelineUrinary tract infections (third revision)]. Huisarts Wet. 2013;56(6):270-80.
42. Janssens HJEM, Lagro HAHM, Van Peet PG, Gorter KJ, Van der Pas P, Van der Paardt M, Woutersen-Koch H. [NHG guidelineosteoarthritis (first version)]. Huisarts Wet. 2009;52(9):439-53.
43. Bouma M, Burgers J, Drost B, Den Elzen WPJ, Luchtman T, OosterhuisWP, Woutersen-Koch H, Van Wijk M; NHG-werkgroep Anemie. [NHG guidelineemia (first revision)]. Huisarts Wet. 2014;57(10):528-36.
44. Dekker F, Van Duijn NP, Ongering JEP, Bartelink MEL, Boelman L, Burgers JS, Bouma M, Kurver MJ. [NHG guideline Headache (thirdrevision)]. Huisarts Wet. 2014;57(1):20-31.
45. Venekamp RP, De Sutter A, Sachs A, Bons SCS, Wiersma TJ, De Jongh E. [NHG guidelineAcute rhinosinusitis (third revision)]. Huisarts Wet. 2014;57(10):537.